February 3, 2026

MannKind Corporation (MNKD) Stock Analysis: A Promising 59.92% Upside with Strong Buy Ratings

MannKind Corporation (NASDAQ: MNKD) stands out in the biotechnology sector with its innovative focus on therapeutic products for endocrine and orphan lung diseases. Based in Danbury, Connecticut, MannKind has carved..

Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 77.43% Potential Upside Amidst Innovative Drug Discovery and Software Growth

Schrodinger, Inc. (NASDAQ: SDGR), a pivotal player in the healthcare sector’s Health Information Services industry, is capturing investor attention with a striking 77.43% potential upside. This New York-based company, founded..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Promising 37.97% Upside Awaits Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a notable player in the healthcare industry, specifically within the drug manufacturing sector, presents an intriguing opportunity for investors seeking growth in the biopharmaceutical space...

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 16% Potential Upside

Kestra Medical Technologies, Ltd. (KMTS) stands at the intersection of healthcare innovation and investment opportunity. This Kirkland, Washington-based company, with a market capitalization of $1.46 billion, is making notable strides..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Potential 25.73% Upside with Promising CNS Portfolio

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, specializes in developing and commercializing innovative treatments for central nervous system (CNS) diseases. With a market capitalization of $2.8..

Agios Pharmaceuticals (AGIO): Investor Outlook on a Biotech with 30.5% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to cellular metabolism and promising pipeline of treatments. With a market capitalization of $1.64..

LivaNova PLC (LIVN) Stock Analysis: Promising 9.35% Upside as Healthcare Innovator Surges

LivaNova PLC (NASDAQ: LIVN), the UK-based medical device company, is making waves in the healthcare sector with a robust growth trajectory and an impressive market capitalization of $3.65 billion. Specializing..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 23.95% Potential Upside in the Medical Devices Sector

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector’s medical devices industry, offers intriguing investment potential with a notable 23.95% upside based on current analyst ratings. Headquartered in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Unpacking a 165% Potential Upside in the Biotech Arena

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention with its compelling potential upside of 165.03%, as analysts set an average target price of $24.25, significantly higher than its current..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Unlocking a 71% Upside Potential in Bioelectric Medicine

Pulse Biosciences, Inc. (NASDAQ: PLSE), a leading player in the bioelectric medicine sector, is capturing the attention of investors with its promising technology and significant upside potential. Despite its current..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 16.84% Potential Upside in Medical Devices

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leading name in the healthcare sector, is capturing the attention of investors with its innovative approach to medical devices, particularly in the field..

The Pennant Group, Inc. (PNTG) Stock Analysis: Analysts Predict 32.88% Upside for Healthcare Innovator

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Eagle, Idaho, and operations spread across..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 164.92% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH) is a compelling name in the healthcare sector, particularly in the health information services industry. Specializing in specialty care management services across oncology, cardiology, and..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential and Investor Insights

NeoGenomics, Inc. (NYSE: NEO) is carving a significant niche in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.59 billion, this U.S.-based company..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 25.91% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) stands out in the healthcare sector, particularly within the medical care facilities industry, with its robust growth trajectory and a promising upside potential for..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 60.79% Potential Upside

For investors seeking opportunities in the healthcare sector, Astrana Health Inc. (ASTH) presents a compelling case with its considerable potential upside of 60.79%. As a healthcare management company based in..

Arcellx, Inc. (ACLX) Stock Analysis: Unveiling A 61.73% Potential Upside in Biotechnology

Arcellx, Inc. (NASDAQ: ACLX) stands out in the biotechnology sector with its innovative approach to immunotherapy, aiming to tackle some of the most challenging cancer forms. With a market capitalization..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 45% Potential Upside Awaits Investors

For investors eyeing the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents itself as a promising opportunity with a projected potential upside of 45.3%. Specializing in innovative bioproduction products and..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unveiling a 69.88% Upside Potential in the Medical Devices Sector

Alphatec Holdings, Inc. (ATEC), a prominent player in the healthcare sector, specifically in the medical devices industry, is drawing significant attention from investors due to its promising upside potential. With..

Search

Funds

February 3, 2026

Search

Funds

February 3, 2026

FTSE 100

Funds